As of April 2024 Editas Medicine has a market cap of $0.45 Billion. This makes Editas Medicine the world's 6046th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.45 B | -44.84% |
2023 | $0.82 B | 35.65% |
2022 | $0.60 B | -66.41% |
2021 | $1.81 B | -58.45% |
2020 | $4.37 B | 171.53% |
2019 | $1.60 B | 45.09% |
2018 | $1.10 B | -14.3% |
2017 | $1.29 B | 117.56% |
2016 | $0.59 B |
On Apr 17th, 2024 the market cap of Editas Medicine was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Organovo ONVO | $12.79 M | -97.20% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.38 B | -16.72% | ๐ฌ๐ง UK |
Novavax NVAX | $0.55 B | 20.66% | ๐บ๐ธ USA |
Novocure
NVCR | $1.29 B | 183.80% | Jersey |